Andrew L Graham Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew L Graham.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew L Graham. Andrew L Graham is Chief Financial Officer in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director of Finance in SYNAGEVA BIOPHARMA CORP ($GEVA).
Andrew L Graham in SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew L Graham: Chief Financial Officer, Director of Finance
Holdings: 0 shares
Latest Transaction: Apr 01 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew L Graham in SYNAGEVA BIOPHARMA CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 7.04 | 3,322 | 23,387 | 3,322 | |
| Jan 02 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 6.99 | 3,322 | 23,221 | 3,322 | |
| Oct 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 7.69 | 3,322 | 25,546 | 3,322 | |
| Aug 17 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 7.05 | 3,322 | 23,420 | 3,322 | |
| Apr 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 6.86 | 2,813 | 19,297 | 2,813 | |
| Jan 04 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 12.54 | 2,813 | 35,275 | 2,813 | |
| Oct 02 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 8.58 | 2,813 | 24,136 | 2,813 | |
| Aug 09 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 8.79 | 2,813 | 24,726 | 2,813 | |
| Apr 03 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 12.80 | 1,696 | 21,709 | 1,696 | |
| Jan 03 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 11.79 | 1,696 | 19,996 | 1,696 | |
| Oct 03 2005 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 15.65 | 1,696 | 26,542 | 1,696 | |
| Aug 11 2005 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 12.62 | 1,696 | 21,404 | 1,696 |
Page: 1